1. Komiya Yoji, Kamiya Mari, Hosoya Tadashi, Oba Seiya, Kawata Daisuke, Iwai Hideyuki, Miyamoto Sho, Kanno Takayuki, Ainai Akira, Suzuki Tadaki, Hasegawa Hideki, Yasuda Shinsuke. 肺胞上皮細胞におけるFASを介したネクロプトーシスの抑制はCOVID-19マウスモデルにおける肺傷害とその後のインフラマソーム活性化を抑制する(Inhibition of FAS-mediated necroptosis in alveolar epithelial cell suppresses lung injury and subsequent inflammasome activation in murine COVID-19 model). 日本免疫学会総会・学術集会記録 2023.12.01

  2. Komiya Yoji, Kamiya Mari, Hosoya Tadashi, Oba Seiya, Kawata Daisuke, Iwai Hideyuki, Miyamoto Sho, Kanno Takayuki, Ainai Akira, Suzuki Tadaki, Hasegawa Hideki, Yasuda Shinsuke. 肺胞上皮細胞におけるFASを介したネクロプトーシスの抑制はCOVID-19マウスモデルにおける肺傷害とその後のインフラマソーム活性化を抑制する(Inhibition of FAS-mediated necroptosis in alveolar epithelial cell suppresses lung injury and subsequent inflammasome activation in murine COVID-19 model). 日本免疫学会総会・学術集会記録 2023.12.01

  1. Mari Kamiya, Marina Tsuchida, Hirokazu Sasaki, Natuka Umezawa, Shinsuke Yasuda. Glucagon-like peptide-1 receptor agonist ameliorates inflammatory myopathies via suppressing muscle fiber necroptosis. The 51st Annual Meeting of the Japanese Society for Immunology 2022.12.09 Kumamoto, Japan

  2. Shinsuke Yasuda, Mari Kamiya, Fumitaka Mizoguchi, Kimito Kawahata, Dengli Wang, Masahiro Nishibori, Jessica Day, Cynthia Louis, Ian P Wicks, Hitoshi Kohsaka . Targeting Necroptosis in Muscle Fibers in Polymyositis. ACR Convergence 2022 2022.11.13 Philadelphia, Pennsylvania, USA

  3. Hosoya Tadashi, Oba Seiya, Komiya Yoji, Kawata Daisuke, Kamiya Mari, Iwai Hideyuki, Miyamoto Sho, Kanno Takayuki, Ainai Akira, Suzuki Tadaki, Hasegawa Hideki, Yasuda Shinsuke. Infection and Immunity II(The underlying mechanism of the deterioration in obese patients with COVID-19). 日本免疫学会総会・学術集会記録 2022.11.01

  4. Baba Hiroyuki, Hosoya Tadashi, Kondo Yuma, Ishida Ryosuke, Hatsuzawa Saki, Kagechika Hiroyuki, Yasuda Shinsuke. Cytokines and Chemokines-1(Anti-inflammatory effects of novel NF-κB inhibitory compounds in two inflammatory animal models). 日本免疫学会総会・学術集会記録 2022.11.01

  5. Hosoya Tadashi, Oba Seiya, Komiya Yoji, Kawata Daisuke, Kamiya Mari, Iwai Hideyuki, Miyamoto Sho, Kanno Takayuki, Ainai Akira, Suzuki Tadaki, Hasegawa Hideki, Yasuda Shinsuke. 感染と免疫II　COVID-19の肥満患者における悪化の根本的なメカニズム(Infection and Immunity II　The underlying mechanism of the deterioration in obese patients with COVID-19). 日本免疫学会総会・学術集会記録 2022.11.01

  6. Baba Hiroyuki, Hosoya Tadashi, Kondo Yuma, Ishida Ryosuke, Hatsuzawa Saki, Kagechika Hiroyuki, Yasuda Shinsuke. サイトカインとケモカイン-1　二つの炎症性動物モデルにおける新規NF-κB阻害化合物の抗炎症作用(Cytokines and Chemokines-1　Anti-inflammatory effects of novel NF-κB inhibitory compounds in two inflammatory animal models). 日本免疫学会総会・学術集会記録 2022.11.01

  7. Hosoya Tadashi, Oba Seiya, Komiya Yoji, Kawata Daisuke, Kamiya Mari, Iwai Hideyuki, Miyamoto Sho, Kanno Takayuki, Ainai Akira, Suzuki Tadaki, Hasegawa Hideki, Yasuda Shinsuke. Infection and Immunity II(The underlying mechanism of the deterioration in obese patients with COVID-19). 日本免疫学会総会・学術集会記録 2022.11.01

  8. Hosoya Tadashi, Oba Seiya, Komiya Yoji, Kawata Daisuke, Kamiya Mari, Iwai Hideyuki, Miyamoto Sho, Kanno Takayuki, Ainai Akira, Suzuki Tadaki, Hasegawa Hideki, Yasuda Shinsuke. 感染と免疫II　COVID-19の肥満患者における悪化の根本的なメカニズム(Infection and Immunity II　The underlying mechanism of the deterioration in obese patients with COVID-19). 日本免疫学会総会・学術集会記録 2022.11.01

  9. Mari Kamiya, Fumitaka Mizoguchi, Hirokazu Sasaki, Natsuka Umezawa, Shinsuke Yasuda. Agonistic stimulation of Glucagon-like peptide-1 receptor ameliorated inflammatory myopathies through suppressing muscle fiber necroptosis. EULAR2022 2022.06.02 Bella Center Copenhagen, Copenhagen, Denmark

  10. Mari Kamiya, Fumitaka Mizoguchi, Shinsuke Yasuda. Agonistic stimulation of Glucagon-like peptide-1 receptor ameliorates experimental polymyositis through inhibiting muscle fiber necroptosis. 66th Annual General Assembly and Scientific Meeting of the Japan College of Rheumatology 2022.04.26 Yokohama, Japan

  1. Seiya Oba, Tadashi Hosoya, Shinsuke Yasuda. Arterial and venous thrombosis complicated in COVID-19; a retrospective single center analysis in Japan. The 50th Annual Meeting of the Japanese Society for Immunology 2021.12.09

  2. Mari Kamiya, Shinsuke Yasuda. Targeting necroptosis in muscle fibers ameliorates experimental inflammatory myopathies. The 50 th Annual Meeting of the Japanese Society for Immunology 2021.12.09 Nara, Japan

  3. Mari Kamiya, Fumitaka Mizoguchi, Hirokazu Sasaki, Natsuka Umezawa, and Shinsuke Yasuda. Glucagon-like Peptide-1 Receptor Agonist Suppresses Muscle Fiber Necroptosis and Muscle Inflammation and Ameliorates Muscle Weakness in Experimental Polymyositis. ACR Convergence 2021 2021.11.07

  4. Tadashi Hosoya, Yasuhiro Tagawa, Hiroyuki Baba, Seiji Noda, Shinsuke Yasuda. Cyclin Dependent Kinase 4 and 6 Determine the Cytokine Responsiveness by Stabilizing JUN in Rheumatoid Arthritis Synovial Fibroblasts.. ACR Convergence 2021 2021.11.06

  5. Hosoya Tadashi, Tagawa Yasuhiro, Baba Hiroyuki, Noda Seiji, Yasuda Shinsuke. 関節リウマチ滑膜線維芽細胞においてサイクリン依存性キナーゼ4および6の活性化はJUNを安定化させることによりMMP-1/3産生に寄与している(The active cyclin dependent kinase 4 and 6 contributed in the MMP-1/3 productions by stabilizing JUN in rheumatoid arthritis synovial fibroblasts). 日本免疫学会総会・学術集会記録 2021.11.01

  6. Oba Seiya, Hosoya Tadashi, Yasuda Shinsuke. COVID-19に合併した動脈および静脈血栓症　日本における後向き単施設解析(Arterial and venous thrombosis complicated in COVID-19: a retrospective single center analysis in Japan). 日本免疫学会総会・学術集会記録 2021.11.01

  7. Oba Seiya, Hosoya Tadashi, Yasuda Shinsuke. COVID-19に合併した動脈および静脈血栓症　日本における後向き単施設解析(Arterial and venous thrombosis complicated in COVID-19: a retrospective single center analysis in Japan). 日本免疫学会総会・学術集会記録 2021.11.01

  8. Noda Seiji, Hosoya Tadashi, Tagawa Yasuhiro, Yasuda Shinsuke. CD34+THY1+滑膜線維芽細胞サブセットにおける著明な骨形成能と軟骨形成能(Remarkable osteogenic and chondrogenic potentials in CD34+ THY1+ synovial fibroblast subest). 日本免疫学会総会・学術集会記録 2021.11.01

  9. Noda Seiji, Hosoya Tadashi, Tagawa Yasuhiro, Yasuda Shinsuke. CD34+THY1+滑膜線維芽細胞サブセットにおける著明な骨形成能と軟骨形成能(Remarkable osteogenic and chondrogenic potentials in CD34+ THY1+ synovial fibroblast subest). 日本免疫学会総会・学術集会記録 2021.11.01

  10. Hosoya Tadashi, Tagawa Yasuhiro, Baba Hiroyuki, Noda Seiji, Yasuda Shinsuke. 関節リウマチ滑膜線維芽細胞においてサイクリン依存性キナーゼ4および6の活性化はJUNを安定化させることによりMMP-1/3産生に寄与している(The active cyclin dependent kinase 4 and 6 contributed in the MMP-1/3 productions by stabilizing JUN in rheumatoid arthritis synovial fibroblasts). 日本免疫学会総会・学術集会記録 2021.11.01

  11. Noda Seiji, Hosoya Tadashi, Tagawa Yasuhiro, Yasuda Shinsuke. Remarkable osteogenic and chondrogenic potentials in CD34+ THY1+ synovial fibroblast subest(和訳中). 日本免疫学会総会・学術集会記録 2021.11.01

  12. Hosoya Tadashi, Tagawa Yasuhiro, Baba Hiroyuki, Noda Seiji, Yasuda Shinsuke. The active cyclin dependent kinase 4 and 6 contributed in the MMP-1/3 productions by stabilizing JUN in rheumatoid arthritis synovial fibroblasts(和訳中). 日本免疫学会総会・学術集会記録 2021.11.01

  13. Oba Seiya, Hosoya Tadashi, Yasuda Shinsuke. Arterial and venous thrombosis complicated in COVID-19: a retrospective single center analysis in Japan(和訳中). 日本免疫学会総会・学術集会記録 2021.11.01

  14. Hosoya Tadashi, Tagawa Yasuhiro, Baba Hiroyuki, Noda Seiji, Yasuda Shinsuke. 関節リウマチ滑膜線維芽細胞においてサイクリン依存性キナーゼ4および6の活性化はJUNを安定化させることによりMMP-1/3産生に寄与している(The active cyclin dependent kinase 4 and 6 contributed in the MMP-1/3 productions by stabilizing JUN in rheumatoid arthritis synovial fibroblasts). 日本免疫学会総会・学術集会記録 2021.11.01

  15. Noda Seiji, Hosoya Tadashi, Tagawa Yasuhiro, Yasuda Shinsuke. CD34+THY1+滑膜線維芽細胞サブセットにおける著明な骨形成能と軟骨形成能(Remarkable osteogenic and chondrogenic potentials in CD34+ THY1+ synovial fibroblast subest). 日本免疫学会総会・学術集会記録 2021.11.01

  16. Oba Seiya, Hosoya Tadashi, Yasuda Shinsuke. COVID-19に合併した動脈および静脈血栓症　日本における後向き単施設解析(Arterial and venous thrombosis complicated in COVID-19: a retrospective single center analysis in Japan). 日本免疫学会総会・学術集会記録 2021.11.01

  17. Masatoshi Takagi, Chitose Ogawa, Tomoko Iehara, Yuki Aoki-Nogami, Eri Isibashi, Minoru Imai, Toshimi Kimura, Masashi Nagata, Masato Yasuhara, Mitsuko Masutani, Kenichi Yoshimura, Daisuke Tomizawa, Atsushi Ogawa, Kan Yonemori, Tetsuro Kihara, Kiyoshi Nobori, Kazuhisa Hasebe, Shuki Mizutani, Tomohiro Morio, Hajime Hosoi, Ryuji Koike. First In Children Phase I Clinical Study Of Oral Olaparib In Pediatric Patients With Refractory Solid Tumors. SIOP2021 2021.10.24 Honolulu（Web）

  18. Tadashi Hosoya, Hiroyuki Baba, Shinsuke Yasuda, Maripat Corr. Novel compound that impacts migration and chemokine production via NFkB suppressing activity. 日本リウマチ学会総会 International Concurrent Workshop 2021.04.28

  19. Mari Kamiya, Shinsuke Yasuda, Fumitaka Mizoguchi. HMGB1 is highly expressed in injured muscle fibers and accelerates inflammation and muscle injury in inflammatory myopathies. 65th Annual General Assembly and Scientific Meeting of the Japan College of Rheumatology 2021.04.27

  1. Mari Kamiya, Seon Uk Kim, Jeong Yeon Kim, Shinsuke Yasuda, Eun Young Lee, Fumitaka Mizoguchi. Glucagon-like Peptide-1 Receptor Agonist Suppresses Muscle Inflammation and Muscle Fiber Death, and Ameliorates Muscle Weakness in Experimental Polymyositis. ACR Convergence 2020 2020.11.09 Online

  2. Identification of Small Molecules with Efficacy as Steroid Sparing Suppression of Chemokine and Cytokine Production by Rheumatoid Arthritis Fibroblast-like Synoviocytes. 2020.10.01

  3. Mari Kamiya, Kimito Kawahata, Hitoshi Kohsaka , Fumitaka Mizoguchi. Targeting necroptosis in muscle cells ameliorates inflammatory myopathies. 64th Annual General Assembly and Scientific Meeting of the Japan College of Rheumatology 2020.08.17

  4. Yamaguchi Ayako, Hirata Shintaro, Miyamoto Toshiaki, Tanimura Kazuhide, Iwai Hideyuki, Kaneko Yuko, Takeuchi Tsutomu, Amano Koichi, Iwamoto Naoki, Kawakami Atsushi, Murakami Miho, Nishimoto Norihiro, Atsumi Tatsuya, Sumida Takayuki, Mimori Tsuneyo, Yamanaka Hisashi, Fujio Keishi, Nakano Kazuhisa, Tanaka Yoshiya. RAの治療戦略　RA患者における持続的寛解後のdrug-free寛解の可能性　FREE-J studyの2年間の成績、リアルワールド前向き観察コホート研究(Treatment strategy of RA　Possibility of drug free remission after sustained remission in patients with RA - The two-year results of the FREE-J study, a real world prospective observational cohort study). 日本リウマチ学会総会・学術集会プログラム・抄録集 2020.08.01

  5. Yamaguchi Ayako, Hirata Shintaro, Miyamoto Toshiaki, Tanimura Kazuhide, Iwai Hideyuki, Kaneko Yuko, Takeuchi Tsutomu, Amano Koichi, Iwamoto Naoki, Kawakami Atsushi, Murakami Miho, Nishimoto Norihiro, Atsumi Tatsuya, Sumida Takayuki, Mimori Tsuneyo, Yamanaka Hisashi, Fujio Keishi, Nakano Kazuhisa, Tanaka Yoshiya. RAの治療戦略　RA患者における持続的寛解後のdrug-free寛解の可能性　FREE-J studyの2年間の成績、リアルワールド前向き観察コホート研究(Treatment strategy of RA　Possibility of drug free remission after sustained remission in patients with RA - The two-year results of the FREE-J study, a real world prospective observational cohort study). 日本リウマチ学会総会・学術集会プログラム・抄録集 2020.08.01

  6. Yamaguchi Ayako, Hirata Shintaro, Miyamoto Toshiaki, Tanimura Kazuhide, Iwai Hideyuki, Kaneko Yuko, Takeuchi Tsutomu, Amano Koichi, Iwamoto Naoki, Kawakami Atsushi, Murakami Miho, Nishimoto Norihiro, Atsumi Tatsuya, Sumida Takayuki, Mimori Tsuneyo, Yamanaka Hisashi, Fujio Keishi, Nakano Kazuhisa, Tanaka Yoshiya. RAの治療戦略　RA患者における持続的寛解後のdrug-free寛解の可能性　FREE-J studyの2年間の成績、リアルワールド前向き観察コホート研究(Treatment strategy of RA　Possibility of drug free remission after sustained remission in patients with RA - The two-year results of the FREE-J study, a real world prospective observational cohort study). 日本リウマチ学会総会・学術集会プログラム・抄録集 2020.08.01

  7. Yamaguchi Ayako, Hirata Shintaro, Miyamoto Toshiaki, Tanimura Kazuhide, Iwai Hideyuki, Kaneko Yuko, Takeuchi Tsutomu, Amano Koichi, Iwamoto Naoki, Kawakami Atsushi, Murakami Miho, Nishimoto Norihiro, Atsumi Tatsuya, Sumida Takayuki, Mimori Tsuneyo, Yamanaka Hisashi, Fujio Keishi, Nakano Kazuhisa, Tanaka Yoshiya. RAの治療戦略　RA患者における持続的寛解後のdrug-free寛解の可能性　FREE-J studyの2年間の成績、リアルワールド前向き観察コホート研究(Treatment strategy of RA　Possibility of drug free remission after sustained remission in patients with RA - The two-year results of the FREE-J study, a real world prospective observational cohort study). 日本リウマチ学会総会・学術集会プログラム・抄録集 2020.08.01

  8. Yamaguchi Ayako, Hirata Shintaro, Miyamoto Toshiaki, Tanimura Kazuhide, Iwai Hideyuki, Kaneko Yuko, Takeuchi Tsutomu, Amano Koichi, Iwamoto Naoki, Kawakami Atsushi, Murakami Miho, Nishimoto Norihiro, Atsumi Tatsuya, Sumida Takayuki, Mimori Tsuneyo, Yamanaka Hisashi, Fujio Keishi, Nakano Kazuhisa, Tanaka Yoshiya. RAの治療戦略　RA患者における持続的寛解後のdrug-free寛解の可能性　FREE-J studyの2年間の成績、リアルワールド前向き観察コホート研究(Treatment strategy of RA　Possibility of drug free remission after sustained remission in patients with RA - The two-year results of the FREE-J study, a real world prospective observational cohort study). 日本リウマチ学会総会・学術集会プログラム・抄録集 2020.08.01

  9. Yamaguchi Ayako, Hirata Shintaro, Miyamoto Toshiaki, Tanimura Kazuhide, Iwai Hideyuki, Kaneko Yuko, Takeuchi Tsutomu, Amano Koichi, Iwamoto Naoki, Kawakami Atsushi, Murakami Miho, Nishimoto Norihiro, Atsumi Tatsuya, Sumida Takayuki, Mimori Tsuneyo, Yamanaka Hisashi, Fujio Keishi, Nakano Kazuhisa, Tanaka Yoshiya. RAの治療戦略　RA患者における持続的寛解後のdrug-free寛解の可能性　FREE-J studyの2年間の成績、リアルワールド前向き観察コホート研究(Treatment strategy of RA　Possibility of drug free remission after sustained remission in patients with RA - The two-year results of the FREE-J study, a real world prospective observational cohort study). 日本リウマチ学会総会・学術集会プログラム・抄録集 2020.08.01

  10. Yamaguchi Ayako, Hirata Shintaro, Miyamoto Toshiaki, Tanimura Kazuhide, Iwai Hideyuki, Kaneko Yuko, Takeuchi Tsutomu, Amano Koichi, Iwamoto Naoki, Kawakami Atsushi, Murakami Miho, Nishimoto Norihiro, Atsumi Tatsuya, Sumida Takayuki, Mimori Tsuneyo, Yamanaka Hisashi, Fujio Keishi, Nakano Kazuhisa, Tanaka Yoshiya. RAの治療戦略　RA患者における持続的寛解後のdrug-free寛解の可能性　FREE-J studyの2年間の成績、リアルワールド前向き観察コホート研究(Treatment strategy of RA　Possibility of drug free remission after sustained remission in patients with RA - The two-year results of the FREE-J study, a real world prospective observational cohort study). 日本リウマチ学会総会・学術集会プログラム・抄録集 2020.08.01

  11. Yamaguchi Ayako, Hirata Shintaro, Miyamoto Toshiaki, Tanimura Kazuhide, Iwai Hideyuki, Kaneko Yuko, Takeuchi Tsutomu, Amano Koichi, Iwamoto Naoki, Kawakami Atsushi, Murakami Miho, Nishimoto Norihiro, Atsumi Tatsuya, Sumida Takayuki, Mimori Tsuneyo, Yamanaka Hisashi, Fujio Keishi, Nakano Kazuhisa, Tanaka Yoshiya. RAの治療戦略　RA患者における持続的寛解後のdrug-free寛解の可能性　FREE-J studyの2年間の成績、リアルワールド前向き観察コホート研究(Treatment strategy of RA　Possibility of drug free remission after sustained remission in patients with RA - The two-year results of the FREE-J study, a real world prospective observational cohort study). 日本リウマチ学会総会・学術集会プログラム・抄録集 2020.08.01

  12. Yamaguchi Ayako, Hirata Shintaro, Miyamoto Toshiaki, Tanimura Kazuhide, Iwai Hideyuki, Kaneko Yuko, Takeuchi Tsutomu, Amano Koichi, Iwamoto Naoki, Kawakami Atsushi, Murakami Miho, Nishimoto Norihiro, Atsumi Tatsuya, Sumida Takayuki, Mimori Tsuneyo, Yamanaka Hisashi, Fujio Keishi, Nakano Kazuhisa, Tanaka Yoshiya.. Treatment strategy of RA 　 Possibility of drug free remission after sustained remission in patients with RA - The two-year results of the FREE-J study, a real world prospective observational cohort study. 64th Annual General Assembly and Scientific Meeting of the Japan College of Rheumatology 2020.08

  13. Mari Kamiya, Seon Uk Kim, Jeong Yeon Kim, Yeong Wook Song, Eun Young Lee, Fumitaka Mizoguchi. Glucagon-like peptide-1 receptor agonist ameliorated muscle weakness and inflammation in experimental polymyositis. European Congress of Rheumatology (EULAR) 2020 2020.06.06

  14. Ayibieke Alafate, 山田 景士, 相曽 啓史, 羽田野 義郎, 貫井 陽子, 小池 竜司, 東田 修二, 齋藤 良一. 東京の2病院で分離された血中のS.epidermidisの疫学的特性(Epidemiological characteristics of bloodstream S. epidermidis isolates from two hospitals in Tokyo). 日本細菌学雑誌 2020.01.01

  15. Ayibieke Alafate, 山田 景士, 相曽 啓史, 羽田野 義郎, 貫井 陽子, 小池 竜司, 東田 修二, 齋藤 良一. 東京の2病院で分離された血中のS.epidermidisの疫学的特性(Epidemiological characteristics of bloodstream S. epidermidis isolates from two hospitals in Tokyo). 日本細菌学雑誌 2020.01.01

  16. Ayibieke Alafate, 山田 景士, 相曽 啓史, 羽田野 義郎, 貫井 陽子, 小池 竜司, 東田 修二, 齋藤 良一. 東京の2病院で分離された血中のS.epidermidisの疫学的特性(Epidemiological characteristics of bloodstream S. epidermidis isolates from two hospitals in Tokyo). 日本細菌学雑誌 2020.01.01

  1. Mari Kamiya, Kimito Kawahata, Hitoshi Kohsaka, Fumitaka Mizoguchi. Inhibition of Necroptosis Suppresses Muscle Cell Death and Inflammatory Infiltrate, and Improves Muscle Strength in Experimental Polymyositis. 2019 ACR/ARP Annual meeting 2019.11.10 Atlanta, GA, USA

  2. 嶋村 抄苗, 保田 晋助, 河野 通仁, 藤枝 雄一郎, 加藤 将, 奥 健志, 渥美 達也. 関節リウマチ患者の線維芽細胞様滑膜細胞においてfarnesyltransferase阻害薬はRasGRP4-RAS-MAPキナーゼ経路を抑制する(Farnesyltransferase inhibitor suppresses the RasGRP4-Ras- MAP kinase pathway in fibroblast-like synoviocytes from patients with rheumatoid arthritis). 日本臨床免疫学会総会プログラム・抄録集 2019.10.01

  3. Naoki Kimura, Hitoshi Kohsaka. Branched chain amino acids in the treatment of polymyositis and dermatomyositis：results from the BTOUGH study.. Annual European Congress of Rheumatology 2019 (EULAR 2019) 2019.06.14 Madrid, Spain

  4. Mari Kamiya, Fumitaka Mizoguchi, Kimito Kawahata, Hitoshi Kohsaka. Inhibition of necroptosis ameliorates in vitro and in vivo models of polymyositis. 63rd Annual General Assembly and Scientific Meeting of the Japan College of Rheumatology 2019.04.16 Kyoto International Conference Center, Kyoto, Japan

  1. Three Year Outcomes of Patients with Elderly-Onset Rheumatoid Arthritis Treated with a Therapeutic Strategy Targeting Low Disease Activity, and Impact of Adverse Events on Physical Function. 2018.09.01

  2. Sugihara Takahiko, Ishizaki Tatsuro, Baba Hiroyuki, Matsumoto Takumi, Iga Shoko, Kusuda Takeshi, Tsuchida Marina, Kamiya Mari, Komiya Yoji, Hirano Fumio, Hosoya Tadashi, Miyasaka Nobuyuki, Harigai Masayoshi. Three Year Outcomes of Patients with Elderly-Onset Rheumatoid Arthritis Treated with a Therapeutic Strategy Targeting Low Disease Activity, and Impact of Adverse Events on Physical Function. 2018 ACR/ARP Annual meeting 2018.09

  3. Mari Kamiya, Naoki Kimura, Akito Takamura, Fumitaka Mizoguchi, Kimito Kawahata, Hitoshi Kohsaka. Cytotoxic T lymphocytes induced perforin/granzyme-dependent apoptosis of myoblasts and Fas/FasL-dependent necroptosis of myotubes in in vitro model of myositis.. JCR international School 2018 2018.08.02

  4. Oku Kenji, Atsumi Tatsuya, Akiyama Yuji, Amano Hirofumi, Azuma Naoto, Bohgaki Toshiyuki, Funakubo Asanuma Yu, Horita Tetsuya, Hosoya Tadashi, Ichinose Kunihiro, Kato Masaru, Katsumata Yasuhiro, Kawaguchi Yasushi, Kawakami Atsushi, Koga Tomohiro, Kohsaka Hitoshi, Kondo Yuya, Kubo Kanae, Kuwana Masataka, Mimori Akio, Mimori Tsuneyo, Mimura Toshihide, Murakami Kosaku, Nakano Kazuhisa, Nakayamada Shingo, Ogishima Hiroshi, Ohmura Kazumasa, Saito Kazuyoshi, Sano Hajime, Shibuya Mihoko, Takahashi Yuko, Takasaki Yoshinari, Takeuchi Tsutomu, Tamura Naoto, Tanaka Yoshiya, Tsuboi Hiroto, Tsunoda Shinichiro, Yukawa Naoichiro, Yamakawa Noriyuki, Yamamoto Kazuhiko, Sumida Takayuki. Systemic Lupus International Collaborating Clinics(SLICC)によって確立された全身性エリテマトーデスの代替分類基準の評価(Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics(SLICC)). Modern Rheumatology 2018.07.01

  1. Corr Maripat, Woller Sarah, Hosoya Tadashi, Hayashi Tomoko, Messer Karen, Pu Minya, Shukla Nikula, Cottam Howard, Yaksh Tony, Carson Dennis. 全身性免疫疾患　全身性自己免疫疾患に対する奇異な制御法(Systemic immune diseases　Paradoxical Modulation Strategies for Systemic Autoimmune Diseases). 日本免疫学会総会・学術集会記録 2017.12.01

  2. Corr Maripat, Woller Sarah, Hosoya Tadashi, Hayashi Tomoko, Messer Karen, Pu Minya, Shukla Nikula, Cottam Howard, Yaksh Tony, Carson Dennis. 全身性免疫疾患　全身性自己免疫疾患に対する奇異な制御法(Systemic immune diseases　Paradoxical Modulation Strategies for Systemic Autoimmune Diseases). 日本免疫学会総会・学術集会記録 2017.12.01

  3. Corr Maripat, Woller Sarah, Hosoya Tadashi, Hayashi Tomoko, Messer Karen, Pu Minya, Shukla Nikula, Cottam Howard, Yaksh Tony, Carson Dennis. Systemic immune diseases Paradoxical Modulation Strategies for Systemic Autoimmune Diseases(和訳中). 日本免疫学会総会・学術集会記録 2017.12.01

  4. Corr Maripat, Woller Sarah, Hosoya Tadashi, Hayashi Tomoko, Messer Karen, Pu Minya, Shukla Nikula, Cottam Howard, Yaksh Tony, Carson Dennis. 全身性免疫疾患　全身性自己免疫疾患に対する奇異な制御法(Systemic immune diseases　Paradoxical Modulation Strategies for Systemic Autoimmune Diseases). 日本免疫学会総会・学術集会記録 2017.12.01

  5. Corr Maripat, Woller Sarah, Hosoya Tadashi, Hayashi Tomoko, Messer Karen, Pu Minya, Shukla Nikula, Cottam Howard, Yaksh Tony, Carson Dennis. 全身性免疫疾患　全身性自己免疫疾患に対する奇異な制御法(Systemic immune diseases　Paradoxical Modulation Strategies for Systemic Autoimmune Diseases). 日本免疫学会総会・学術集会記録 2017.12.01

  6. Mari Kamiya, Naoki Kimura, Akito Takamura, Fumitaka Mizoguchi, Kimito Kawahata, Hitoshi Kohsaka. Study of in vitro T cell/myotube interaction disclosed invasive and cytotoxic nature of CD8+ cells enclosed in the muscle cells.. 19th Asia Pacific League of Associations for Rheumatology Congress (APLAR 2017) 2017.10.20 Dubai World Trade Center

  7. Tadashi Hosoya, Fumi Sato-Kaneko, Alast Ahmadi, Shiyin Yao, Fitzgerald S Lao, Takaji Matsutani, Dennis A Carson, Tomoko Hayashi. Immunotherapy with a phospholipid-conjugated TLR7 ligand prevents lung metastasis. La Jolla immunology conference 2017.10.18

  8. 梅澤　夏佳、木村　直樹、吉橋洋子、上阪　等. 多発性筋炎/皮膚筋炎患者の前脛骨筋を対象としたコンコトーム筋生検の有用性. 第45回日本臨床免疫学会総会 2017.09.29

  9. Natsuka Umezawa, Kimito Kawahata, Naoki Kimura, Yoko Yoshihashi- Nakazato, Hitoshi Kohsaka. Interleukin-23 as a therapeutic target for inflammatory myopathy. 7th East Asian Group of Rheumatology 2017.07.07

  1. Mizoguchi Fumitaka, Hasegawa Hisanori, Kohsaka Hitoshi. Functional Screening of Micrornas Using the Inhibitor Library Identified Micrornas to Regulate Expression of MMP-3 and IL-6 in Rheumatoid Arthritis Synovial Fibroblasts. 2016 American College of Rheumatology 2016.11.16

  2. Kusuda Takeshi, Hosoya Tadashi, Mori Takayasu, Ihara Katsuhito, Nishida Hidenori, Chiga Motoko, Sohara Eisei, Rai Tatemitsu, Koike Ryuji, Uchida Shinichi, Kohsaka Hitoshi. SLC12A3ヘテロ接合変異を有する抗SSA抗体陽性患者における後天性Gitelman症候群(Acquired Gitelman Syndrome in an Anti-SSA Antibody-positive Patient with a SLC12A3 Heterozygous Mutation). Internal Medicine 2016.11.01

  3. 戸倉 雅, 神谷 麻理, 川畑 仁人, 上阪 等. ステロイド抵抗性心筋炎、心膜炎を呈したシェーグレン症候群. 日本内科学会関東地方会 2016.06

  4. Tsuyoshi Yamada, Hideyuki Iwai, Sayuri Nitta, Masakazu Nagahori, Masayoshi Harigai. Creating Medical Innovators – a Whole-brain Approach to Hea. the 13th Asia Pacific Medical Education Conference 2016.01.15 Singapore

  1. Naoki Kimura, Kimito Kawahata, Hitoshi Kohsaka. Peripheral license for autoimmune-mediated tissue injury revealed from a murine model of polymyositis. The 44th Annual Meeting of the Japanese Society for Immunology 2015.11.20 Sapporo, Japan

  2. Okiyama Naoko, Hasegawa HIsanori, Oida Takatoku, Hirata Shinya, Yokozeki Hiroo, Fujimoto Manabu, Kohsaka Hitoshi. 臓器特異的自己免疫疾患(2) 骨格筋C蛋白由来CD8Tエピトープペプチドを提示する樹状細胞の移入により誘発可能は実験的筋炎. 第44回(2015年)日本免疫学会学術集会 2015.11.19

  3. Hosoya Tadashi, Mizoguchi Fumitaka, Hasegawa Hisanori, Miura Keiko, Koike Ryuji, Kubota Tetsuo, Miyasaka Nobuyuki, Kohsaka Hitoshi. TNFRSF1A遺伝子変異を認めず、トシリズマブ投与が奏効した、腫瘍壊死因子(TNF)受容体関連周期性症候群(TRAPS)の臨床的特徴を示す1症例. Internal Medicine 2015.08.01

  4. F. Hirano,　W. Yokoyama, H. Yamazaki, K. Amano, Y. Kaneko, A. Kawakami, T. Matsui, R. Sakai, R. Koike, N. Miyasaka, M. Harigai. SDAI REMISSION AT WEEK 24 IS A PREDICTOR OF GOOD FUNCTIONAL AND STRUCTURAL OUTCOMES AT WEEK 72 IN A T2T IMPLEMENTING COHORT. EULAR2015 2015.06.11 Rome

  5. Naoki Kimura, Shinya Hirata, Nobuyuki Miyasaka, Kimito Kawahata, Hitoshi Kohsaka. Injury and Subsequent Regeneration of Muscles Activate Local Innate Immunity to Facilitate Development and Relapse of Autoimmune Myositis. First International Conference on MYOSITIS 2015.05.08

  6. Yoko Yoshihashi-Nakazato, Kimito Kawahata, Naoki Kimura, Hitoshi Kohsaka.. Interferon-gamma but not interleukin-4 restrains experimental myositis. . 1st International Conference on Myositis 2015.05.08 Stockholm, Sweden

  7. Naoko Okiyama, Hisanori Hasegawa, Takamori Oida, Sinya Hirata,Hiroo Yokozeki, Manabu Fujimoto, Nobuyuki Miyasaka, Hitoshi Kohsaka.. Experimental Myositis Inducible with Transfer of Dendritic Cells Presenting a Skeletal Muscle C protein-derived CD8 Epitope Peptide.. 1st International Conference on Myositis 2015.05.08 Stockholm, Sweden

  8. Naoki Kimura, Shinya Hirata, Nobuyuki Miyasaka, Kimito Kawahata, Hitoshi Kohsaka.. Injury And Subsequent Regeneration Of Muscles Activate Local Innate Immunity To Facilitate Development And Relapse Of Autoimmune Myositis.. 1st International Conference on Myositis 2015.05.08 Stockholm, Sweden

  9. Naoki Kimura, Shinya Hirata, Nobuyuki Miyasaka, Kimito Kawahata, Hitoshi Kohsaka. Injury and subsequent regeneration of muscles activate local innate immunity to facilitate development and relapse of autoimmune myositis. The 59th Annual General Assembly and Scientific Meeting of the Japan College of Rheumatology 2015.04.24 Nagoya, Japan

  10. Naoki Kimura, Shinya Hirata, Nobuyuki Miyasaka, Kimito Kawahata, Hitoshi Kohsaka.. Injury and subsequent regeneration of muscles activate local innate immunity to facilitate development and relapse of autoimmune myositis. 第59回日本リウマチ学会総会・学術集会 2015.04.23 名古屋

  1. Tadashi Hosoya, Kimito Kawahata,Hideyuki Iwai, Hitoshi Kohsaka. Cell cycle regulation therapy, when combined with TNF blockade, exerted significant therapeutic effects even in the late stage of a rheumatoid arthritis model. ACR/ARHP Annual Meeting 2014.11.18 Boston

  2. The Combination Therapy of Cell Cycle Regulation Therapy Combined and TNF Blockade Ameliorated the Established Arthritis.. 2014.10.01

  3. Tadashi Hosoya, Hideyuki Iwai, Yu Yamaguchi, Nobuyuki Miyasaka, Hitoshi Kohsaka. Cell cycle regulation therapy combined with cytokine blockade enhances anti-arthritic effects without increase of immune suppression.. 58th Annual General Assembly and Scientific Meeting of the Japan College of Rheumatology 2014.04.24 Tokyo

  4. Hosoya Tadashi, Iwai Hideyuki, Yamaguchi Yu, Miyasaka Nobuyuki, Kohsaka Hitoshi. RA、病因　サイトカインの阻害と併用した細胞周期調節療法は免疫抑制を増強することなく関節炎抑制効果を増強する(RA, pathogenesis　Cell cycle regulation therapy combined with cytokine blockade enhances anti-arthritic effects without increase of immune suppression). 日本リウマチ学会総会・学術集会プログラム・抄録集 2014.03.01

  5. Hosoya Tadashi, Iwai Hideyuki, Yamaguchi Yu, Miyasaka Nobuyuki, Kohsaka Hitoshi. 関節リウマチの治療　新しい治療薬　サイトカイン阻害と併用した細胞周期調節療法は免疫抑制を増加させることなく関節炎抑制作用を増強する(Cell cycle regulation therapy combined with cytokine blockade enhances anti-arthritic effects without increase of immune suppression). 日本リウマチ学会総会・学術集会プログラム・抄録集 2014.03.01

  6. Hosoya Tadashi, Iwai Hideyuki, Yamaguchi Yu, Miyasaka Nobuyuki, Kohsaka Hitoshi. 関節リウマチの治療　新しい治療薬 サイトカイン阻害と併用した細胞周期調節療法は免疫抑制を増加させることなく関節炎抑制作用を増強する(Cell cycle regulation therapy combined with cytokine blockade enhances anti-arthritic effects without increase of immune suppression). 日本リウマチ学会総会・学術集会プログラム・抄録集 2014.03.01

  7. Hosoya Tadashi, Iwai Hideyuki, Yamaguchi Yu, Miyasaka Nobuyuki, Kohsaka Hitoshi. RA、病因　サイトカインの阻害と併用した細胞周期調節療法は免疫抑制を増強することなく関節炎抑制効果を増強する(RA, pathogenesis　Cell cycle regulation therapy combined with cytokine blockade enhances anti-arthritic effects without increase of immune suppression). 日本リウマチ学会総会・学術集会プログラム・抄録集 2014.03.01

  8. Hosoya Tadashi, Iwai Hideyuki, Yamaguchi Yu, Miyasaka Nobuyuki, Kohsaka Hitoshi. RA、病因 サイトカインの阻害と併用した細胞周期調節療法は免疫抑制を増強することなく関節炎抑制効果を増強する(RA, pathogenesis Cell cycle regulation therapy combined with cytokine blockade enhances anti-arthritic effects without increase of immune suppression). 日本リウマチ学会総会・学術集会プログラム・抄録集 2014.03.01

  9. Hosoya Tadashi, Iwai Hideyuki, Yamaguchi Yu, Miyasaka Nobuyuki, Kohsaka Hitoshi. RA、病因　サイトカインの阻害と併用した細胞周期調節療法は免疫抑制を増強することなく関節炎抑制効果を増強する(RA, pathogenesis　Cell cycle regulation therapy combined with cytokine blockade enhances anti-arthritic effects without increase of immune suppression). 日本リウマチ学会総会・学術集会プログラム・抄録集 2014.03.01

  10. Hosoya Tadashi, Iwai Hideyuki, Yamaguchi Yu, Miyasaka Nobuyuki, Kohsaka Hitoshi. 関節リウマチの治療　新しい治療薬　サイトカイン阻害と併用した細胞周期調節療法は免疫抑制を増加させることなく関節炎抑制作用を増強する(Cell cycle regulation therapy combined with cytokine blockade enhances anti-arthritic effects without increase of immune suppression). 日本リウマチ学会総会・学術集会プログラム・抄録集 2014.03.01

  11. Hosoya Tadashi, Iwai Hideyuki, Yamaguchi Yu, Miyasaka Nobuyuki, Kohsaka Hitoshi. 関節リウマチの治療　新しい治療薬　サイトカイン阻害と併用した細胞周期調節療法は免疫抑制を増加させることなく関節炎抑制作用を増強する(Cell cycle regulation therapy combined with cytokine blockade enhances anti-arthritic effects without increase of immune suppression). 日本リウマチ学会総会・学術集会プログラム・抄録集 2014.03.01

  12. Hosoya Tadashi, Iwai Hideyuki, Yamaguchi Yu, Miyasaka Nobuyuki, Kohsaka Hitoshi. RA、病因　サイトカインの阻害と併用した細胞周期調節療法は免疫抑制を増強することなく関節炎抑制効果を増強する(RA, pathogenesis　Cell cycle regulation therapy combined with cytokine blockade enhances anti-arthritic effects without increase of immune suppression). 日本リウマチ学会総会・学術集会プログラム・抄録集 2014.03.01

  13. Hosoya Tadashi, Iwai Hideyuki, Yamaguchi Yu, Miyasaka Nobuyuki, Kohsaka Hitoshi. RA、病因　サイトカインの阻害と併用した細胞周期調節療法は免疫抑制を増強することなく関節炎抑制効果を増強する(RA, pathogenesis　Cell cycle regulation therapy combined with cytokine blockade enhances anti-arthritic effects without increase of immune suppression). 日本リウマチ学会総会・学術集会プログラム・抄録集 2014.03.01

  14. Hosoya Tadashi, Iwai Hideyuki, Yamaguchi Yu, Miyasaka Nobuyuki, Kohsaka Hitoshi. 関節リウマチの治療　新しい治療薬　サイトカイン阻害と併用した細胞周期調節療法は免疫抑制を増加させることなく関節炎抑制作用を増強する(Cell cycle regulation therapy combined with cytokine blockade enhances anti-arthritic effects without increase of immune suppression). 日本リウマチ学会総会・学術集会プログラム・抄録集 2014.03.01

  1. Hosoya Tadashi, Iwai Hideyuki, Miyasaka Nobuyuki, Kohsaka Hitoshi. サイトカイン遮断を併用した細胞周期調節療法は、免疫抑制増加を伴わずに抗関節炎効果を増強する(Cell cycle regulation therapy combined with cytokine blockade enhances anti-arthritic effects without increase of immune suppression). 日本免疫学会総会・学術集会記録 2013.11.01

  2. Cell Cycle Regulation Therapy Combined With Cytokine Blockade Enhances Anti-Arthritic Effects Without Increase Of Immune Suppression. 2013.10.01

  3. Hisanori Hasegawa, Fumitaka Mizoguchi, Naoko Okiyama, Miyuki Azuma, Nobuyuki Miyaksaka, Hitoshi Kohsaka. . 6. CD28-CD80/86 blockade by CTLA-4Ig suppresses murine models of polymyositis driven by cytotoxic CD8 T cells. . The 5th East Asian Group of Rheumatology 2013.06.01

  1. Iwai Hideyuki, Hosoya Tadashi, Takenaka Kenchi, Murakami Yousuke, Miyasaka Nobuyuki, Hitoshi Kohsaka. 関節リウマチの新たな治療と評価 マウスTREM-1リガンドの機能解析およびヒトTREM-1リガンドの同定(Functional analysis of mouse TREM-1 ligand and identification of human TREM-1 ligand). 日本免疫学会総会・学術集会記録 2012.11.01

  2. Iwai Hideyuki, Hosoya Tadashi, Takenaka Kenchi, Murakami Yousuke, Miyasaka Nobuyuki, Hitoshi Kohsaka. 関節リウマチの新たな治療と評価　マウスTREM-1リガンドの機能解析およびヒトTREM-1リガンドの同定(Functional analysis of mouse TREM-1 ligand and identification of human TREM-1 ligand). 日本免疫学会総会・学術集会記録 2012.11.01

  3. Iwai Hideyuki, Hosoya Tadashi, Takenaka Kenchi, Murakami Yousuke, Miyasaka Nobuyuki, Hitoshi Kohsaka. 関節リウマチの新たな治療と評価　マウスTREM-1リガンドの機能解析およびヒトTREM-1リガンドの同定(Functional analysis of mouse TREM-1 ligand and identification of human TREM-1 ligand). 日本免疫学会総会・学術集会記録 2012.11.01

  4. Iwai Hideyuki, Hosoya Tadashi, Takenaka Kenchi, Murakami Yousuke, Miyasaka Nobuyuki, Hitoshi Kohsaka. 関節リウマチの新たな治療と評価　マウスTREM-1リガンドの機能解析およびヒトTREM-1リガンドの同定(Functional analysis of mouse TREM-1 ligand and identification of human TREM-1 ligand). 日本免疫学会総会・学術集会記録 2012.11.01

  5. Iwai Hideyuki, Hosoya Tadashi, Takenaka Kenchi, Murakami Yousuke, Miyasaka Nobuyuki, Hitoshi Kohsaka. 関節リウマチの新たな治療と評価　マウスTREM-1リガンドの機能解析およびヒトTREM-1リガンドの同定(Functional analysis of mouse TREM-1 ligand and identification of human TREM-1 ligand). 日本免疫学会総会・学術集会記録 2012.11.01

  6. Treat-to-Target Strategy Aiming At Achievement of Structural and Functional Remission in Patients with Active Elderly-Onset Rheumatoid Arthritis.. 2012.10.01

  1. Hideyuki Iwai, Hosoya Tadashi, Murakami Yousuke, Miyasaka Nobuyuki, Kohsaka Hitoshi. 関節リウマチ 関節炎治療標的としてのB細胞上のTREM-1リガンドの同定(Identification of the TREM-1 ligand on B lymphocytes as a therapeutic target of arthritis). 日本免疫学会総会・学術集会記録 2011.11.01

  2. Hideyuki Iwai, Hosoya Tadashi, Murakami Yousuke, Miyasaka Nobuyuki, Kohsaka Hitoshi. 関節リウマチ　関節炎治療標的としてのB細胞上のTREM-1リガンドの同定(Identification of the TREM-1 ligand on B lymphocytes as a therapeutic target of arthritis). 日本免疫学会総会・学術集会記録 2011.11.01

  3. Hideyuki Iwai, Hosoya Tadashi, Murakami Yousuke, Miyasaka Nobuyuki, Kohsaka Hitoshi. 関節リウマチ　関節炎治療標的としてのB細胞上のTREM-1リガンドの同定(Identification of the TREM-1 ligand on B lymphocytes as a therapeutic target of arthritis). 日本免疫学会総会・学術集会記録 2011.11.01

  4. Hideyuki Iwai, Hosoya Tadashi, Murakami Yousuke, Miyasaka Nobuyuki, Kohsaka Hitoshi. 関節リウマチ　関節炎治療標的としてのB細胞上のTREM-1リガンドの同定(Identification of the TREM-1 ligand on B lymphocytes as a therapeutic target of arthritis). 日本免疫学会総会・学術集会記録 2011.11.01

  5. Hideyuki Iwai, Hosoya Tadashi, Murakami Yousuke, Miyasaka Nobuyuki, Kohsaka Hitoshi. 関節リウマチ　関節炎治療標的としてのB細胞上のTREM-1リガンドの同定(Identification of the TREM-1 ligand on B lymphocytes as a therapeutic target of arthritis). 日本免疫学会総会・学術集会記録 2011.11.01

  1. Kaneko Kayoko, Nanki Toshihiro, Hosoya Tadashi, Mizoguchi Fumitaka, Miyasaka Nobuyuki. 関節リウマチ患者2例におけるエタネルセプトで誘発された壊死性半月体形成性糸球体腎炎(Etanercept-induced necrotizing crescentic glomerulonephritis in two patients with rheumatoid arthritis). Modern Rheumatology 2010.12.01

  2. 中川 久子, 保田 晋助, 松浦 栄次, 小林 和子, 家子 正裕, 片岡 浩, 堀田 哲也, 渥美 達也, 小池 隆夫. ニックβ2-糖蛋白質Iはアンギオスタチン4.5と結合しその血管新生阻害を減弱化する(Nicked β2-glycoprotein I binds angiostatin 4.5 and attenuates its anti-angiogenic property). 日本血栓止血学会誌 2010.04.01

  1. Mari Kamiya. Is muscle fiber death necrosis?. 64th Annual Meetings of the Japanese Society of Neurology 2023.06.01 Chiba, Japan

  2. Mari Kamiya. Targeting muscle fiber necroptosis for treatments of inflammatory myopathies. 67th Annual General Assembly and Scientific Meeting of the Japan College of Rheumatology 2023.04.24

  1. An adult case of A20 haploinsufficiency diagnosed by the development of myocardial infarction due to coronary arteritis. 2020.02.15

  1. An adult case of cytotoxic T-lymphocyte antigen 4 (CTLA-4) insufficiency treated successfully with abatacept. 2019.02.03

  1. Mari Kamiya, Fumitaka Mizoguchi, Naoki Kimura, Akito Takamura, Kimito Kawahata, Hitoshi Kohsaka . In-vitro study of cytotoxic T lymphocyte-mediated muscle injury in polymyositis.. 2018.04.26

To the head of this page.▲